271 related articles for article (PubMed ID: 32024052)
1. Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms.
Dovnik A; Dovnik NF
Cells; 2020 Feb; 9(2):. PubMed ID: 32024052
[TBL] [Abstract][Full Text] [Related]
2. The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention.
Guo H; Guo J; Xie W; Yuan L; Sheng X
J Ovarian Res; 2018 Aug; 11(1):71. PubMed ID: 30157901
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D - pivotal nutraceutical in the regulation of cancer metastasis and angiogenesis.
Xu J; Li W; Ma J; Liu J; Sha H; Zhou S; Wang F; Ma Q
Curr Med Chem; 2013; 20(33):4109-20. PubMed ID: 23895682
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor is a novel drug target for ovarian cancer treatment.
Zhang X; Nicosia SV; Bai W
Curr Cancer Drug Targets; 2006 May; 6(3):229-44. PubMed ID: 16712459
[TBL] [Abstract][Full Text] [Related]
5. 1α,25‑Dihydroxyvitamin D3 restrains stem cell‑like properties of ovarian cancer cells by enhancing vitamin D receptor and suppressing CD44.
Ji M; Liu L; Hou Y; Li B
Oncol Rep; 2019 Jun; 41(6):3393-3403. PubMed ID: 31002352
[TBL] [Abstract][Full Text] [Related]
6. [Current Topics on Vitamin D. Anti-cancer effects of vitamin D].
Watanabe R; Inoue D
Clin Calcium; 2015 Mar; 25(3):373-80. PubMed ID: 25716810
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and VDR in Gynecological Cancers-A Systematic Review.
Deuster E; Jeschke U; Ye Y; Mahner S; Czogalla B
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113037
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
[No Abstract] [Full Text] [Related]
9. Vitamin D endocrine system and psoriasis vulgaris--review of the literature.
Rucević I; Barisić-Drusko V; Glavas-Obrovac L; Stefanić M
Acta Dermatovenerol Croat; 2009; 17(3):187-92. PubMed ID: 19818218
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in Prostate Cancer.
Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer: interplay of vitamin D signaling and miRNA action.
Attar R; Gasparri ML; Donato VD; Yaylim I; Halim TA; Zaman F; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(8):3359-62. PubMed ID: 24870722
[TBL] [Abstract][Full Text] [Related]
12. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
13. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.
Bandera Merchan B; Morcillo S; Martin-Nuñez G; Tinahones FJ; Macías-González M
J Steroid Biochem Mol Biol; 2017 Mar; 167():203-218. PubMed ID: 27913313
[TBL] [Abstract][Full Text] [Related]
14. H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Han N; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245092
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2.
Wang L; Zhou S; Guo B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230936
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells.
Kloss M; Fischer D; Thill M; Friedrich M; Cordes T; Salehin D; Diedrich K; Köster F
Anticancer Res; 2010 Nov; 30(11):4429-34. PubMed ID: 21115889
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
18. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer.
Cordes T; Hoellen F; Dittmer C; Salehin D; Kümmel S; Friedrich M; Köster F; Becker S; Diedrich K; Thill M
Anticancer Res; 2012 Jan; 32(1):351-7. PubMed ID: 22213326
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression.
Thill M; Woeste A; Reichert K; Fischer D; Rody A; Friedrich M; Köster F
Anticancer Res; 2015 Feb; 35(2):1197-203. PubMed ID: 25667511
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?
Buell JS; Dawson-Hughes B
Mol Aspects Med; 2008 Dec; 29(6):415-22. PubMed ID: 18579197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
